Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type I cytoskeletal 14 (K14) is an acidic, low molecular weight intermediate filament protein expressed primarily in the basal cells of stratified squamous epithelia, including the epidermis, where it pairs with keratin 5 to form filaments that provide structural integrity, maintain cell shape, and confer resistance to mechanical stress. It serves as a prototypic marker of mitotically active basal keratinocytes, including stem cells and transient amplifying cells, and plays key roles in regulating the balance between cell proliferation and differentiation through interactions with signaling pathways like PI3K/Akt and Hippo/YAP, as well as modulation of Notch1 activation. Knockdown or mutation of K14 impairs proliferation, delays cell cycle progression, promotes differentiation markers such as involucrin and keratin 1, and reduces tumorigenicity in squamous cell carcinoma models. In disease, K14 mutations cause epidermolysis bullosa simplex, a skin blistering disorder, while its expression marks basal-like breast cancers, squamous cell carcinomas, and aids in distinguishing tumor subtypes like basal vs. non-basal breast carcinomas or benign prostate from carcinoma. Although not a primary therapeutic target like receptors or enzymes, K14 is widely used as a diagnostic biomarker in immunohistochemistry for epithelial tumor classification and prognosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cytoskeletal 14 (K14).